Reporter June 14 2019
Churchwell named interim vice chancellor for equity, diversity and inclusion and chief university diversity officer
Jun. 14, 2019—André L. Churchwell, chief diversity officer for Vanderbilt University Medical Center and senior associate dean for diversity affairs in the Vanderbilt University School of Medicine, has been named interim vice chancellor for equity, diversity and inclusion and chief diversity officer for Vanderbilt University.
Jun. 13, 2019—More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology.
Jun. 13, 2019—A $10 million endowed gift will fund translational research, support clinical programs and create an endowed chair within the Department of Psychiatry.
Jun. 13, 2019—Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).
Jun. 13, 2019—More than 80 people attended a Palliative Care Conference in Nashville recently that was led by faculty members of the Palliative Care programs at VUMC and the Nashville VA Medical Center, and VUMC Center for Biomedical Ethics.
Jun. 13, 2019—Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.
Jun. 13, 2019—Jesse Ehrenfeld, MD, MPH, professor of Anesthesiology, Surgery, Biomedical Informatics and Health Policy, will be departing Vanderbilt to become director of the Advancing a Healthier Wisconsin (AHW) Endowment and senior associate dean at the Medical College of Wisconsin (MCW) School of Medicine effective Sept. 1.
Jun. 13, 2019—The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment. VUMC's Madan Jagasia, MBBS, MS, MMHC, was a lead investigator of the REACH1 trial that was the basis for the FDA approval.
Jun. 13, 2019—Cathy Maxwell, PhD, Shelagh Mulvaney, PhD, and Bethany Rhoten, PhD, have been named Vanderbilt University School of Nursing’s first Valere Potter Distinguished Dean’s Faculty Fellows.
Jun. 13, 2019—Kelly Brown, MD, associate professor of Clinical Neurology, will be assuming the role of executive medical director of the Neurosciences Patient Care Center (PCC) effective July 1.
Jun. 13, 2019—Todd Peterson, PhD, associate professor of Radiology and Radiological Sciences, has been appointed director of the Vanderbilt University Institute of Imaging Science (VUIIS) Radiochemistry Core Lab, following the departure of Michael Nickels, PhD.